

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fucose catabolic process (GO:0019317) | 8.42674782 |
| 2 | L-fucose metabolic process (GO:0042354) | 8.42674782 |
| 3 | L-fucose catabolic process (GO:0042355) | 8.42674782 |
| 4 | positive regulation of endothelial cell differentiation (GO:0045603) | 8.14268340 |
| 5 | definitive hemopoiesis (GO:0060216) | 8.12651075 |
| 6 | ribosomal small subunit assembly (GO:0000028) | 7.57446995 |
| 7 | lymphangiogenesis (GO:0001946) | 7.19742238 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.56413854 |
| 9 | regulation of endothelial cell differentiation (GO:0045601) | 6.28686424 |
| 10 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 6.14425138 |
| 11 | wound healing, spreading of epidermal cells (GO:0035313) | 6.10592535 |
| 12 | angiogenesis involved in wound healing (GO:0060055) | 6.07467748 |
| 13 | negative regulation of fibroblast apoptotic process (GO:2000270) | 6.03207261 |
| 14 | negative regulation of focal adhesion assembly (GO:0051895) | 5.75965710 |
| 15 | negative regulation of cell junction assembly (GO:1901889) | 5.75965710 |
| 16 | negative regulation of adherens junction organization (GO:1903392) | 5.75965710 |
| 17 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.74710826 |
| 18 | mature B cell differentiation involved in immune response (GO:0002313) | 5.65313525 |
| 19 | viral transcription (GO:0019083) | 5.59987037 |
| 20 | endothelial tube morphogenesis (GO:0061154) | 5.54866489 |
| 21 | morphogenesis of an endothelium (GO:0003159) | 5.54866489 |
| 22 | artery development (GO:0060840) | 5.51185307 |
| 23 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 5.50233365 |
| 24 | platelet dense granule organization (GO:0060155) | 5.37543836 |
| 25 | hepatocyte apoptotic process (GO:0097284) | 5.26458231 |
| 26 | translational termination (GO:0006415) | 5.18656906 |
| 27 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.11918863 |
| 28 | megakaryocyte development (GO:0035855) | 5.09231454 |
| 29 | positive regulation of urine volume (GO:0035810) | 4.98844092 |
| 30 | cellular extravasation (GO:0045123) | 4.93689227 |
| 31 | response to interferon-beta (GO:0035456) | 4.92571217 |
| 32 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.89540134 |
| 33 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 4.78306104 |
| 34 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 4.76203264 |
| 35 | maturation of SSU-rRNA (GO:0030490) | 4.74656586 |
| 36 | thrombin receptor signaling pathway (GO:0070493) | 4.73981217 |
| 37 | sprouting angiogenesis (GO:0002040) | 4.71057167 |
| 38 | response to interferon-alpha (GO:0035455) | 4.64506437 |
| 39 | fucosylation (GO:0036065) | 4.55602192 |
| 40 | Peyers patch development (GO:0048541) | 4.50150638 |
| 41 | mucosal-associated lymphoid tissue development (GO:0048537) | 4.50150638 |
| 42 | mast cell activation involved in immune response (GO:0002279) | 4.49341981 |
| 43 | mast cell degranulation (GO:0043303) | 4.49341981 |
| 44 | translational elongation (GO:0006414) | 4.42552592 |
| 45 | fucose metabolic process (GO:0006004) | 4.41587988 |
| 46 | negative regulation of endothelial cell migration (GO:0010596) | 4.36158948 |
| 47 | positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862) | 4.34694763 |
| 48 | lymph vessel development (GO:0001945) | 4.33417272 |
| 49 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.29988171 |
| 50 | positive regulation of granulocyte differentiation (GO:0030854) | 4.28114029 |
| 51 | ribosomal small subunit biogenesis (GO:0042274) | 4.27178264 |
| 52 | mature B cell differentiation (GO:0002335) | 4.24416126 |
| 53 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.24132357 |
| 54 | lymph node development (GO:0048535) | 4.19617595 |
| 55 | negative regulation of platelet activation (GO:0010544) | 4.19617053 |
| 56 | cotranslational protein targeting to membrane (GO:0006613) | 4.13396041 |
| 57 | protein targeting to ER (GO:0045047) | 4.10834652 |
| 58 | neuron remodeling (GO:0016322) | 4.07745046 |
| 59 | histamine secretion (GO:0001821) | 4.07651831 |
| 60 | secretory granule organization (GO:0033363) | 4.07180144 |
| 61 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.05945481 |
| 62 | positive regulation of interleukin-8 secretion (GO:2000484) | 4.05044234 |
| 63 | mast cell activation (GO:0045576) | 4.02269301 |
| 64 | blood coagulation, intrinsic pathway (GO:0007597) | 4.01628921 |
| 65 | necroptotic process (GO:0070266) | 4.01026761 |
| 66 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 4.00398477 |
| 67 | wound healing, spreading of cells (GO:0044319) | 3.99736199 |
| 68 | endothelial cell differentiation (GO:0045446) | 3.98874767 |
| 69 | regulation of fibroblast apoptotic process (GO:2000269) | 3.97805558 |
| 70 | negative regulation of neurological system process (GO:0031645) | 3.97277022 |
| 71 | plasma membrane fusion (GO:0045026) | 3.95515464 |
| 72 | IMP metabolic process (GO:0046040) | 3.94070594 |
| 73 | protein localization to endoplasmic reticulum (GO:0070972) | 3.93802624 |
| 74 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.93165368 |
| 75 | response to magnesium ion (GO:0032026) | 3.89664731 |
| 76 | viral life cycle (GO:0019058) | 3.85856634 |
| 77 | positive regulation of respiratory burst (GO:0060267) | 3.84716886 |
| 78 | regulation of integrin activation (GO:0033623) | 3.82960610 |
| 79 | regulation of histone H3-K9 methylation (GO:0051570) | 3.80910431 |
| 80 | endothelial cell proliferation (GO:0001935) | 3.80705211 |
| 81 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.76893858 |
| 82 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.76893858 |
| 83 | cellular protein complex disassembly (GO:0043624) | 3.75259600 |
| 84 | regulation of urine volume (GO:0035809) | 3.72918970 |
| 85 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 3.72839493 |
| 86 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.71867975 |
| 87 | positive regulation of hemostasis (GO:1900048) | 3.71494190 |
| 88 | positive regulation of blood coagulation (GO:0030194) | 3.71494190 |
| 89 | regulation of sarcomere organization (GO:0060297) | 3.70672097 |
| 90 | glomerular filtration (GO:0003094) | 3.70580916 |
| 91 | positive regulation of odontogenesis (GO:0042482) | 3.67635762 |
| 92 | embryonic hemopoiesis (GO:0035162) | 3.65736776 |
| 93 | regulation of platelet activation (GO:0010543) | 3.64902712 |
| 94 | negative regulation of viral entry into host cell (GO:0046597) | 3.64076604 |
| 95 | negative regulation of endothelial cell proliferation (GO:0001937) | 3.62866965 |
| 96 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 3.62753111 |
| 97 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 3.59705941 |
| 98 | regulation of blood vessel endothelial cell migration (GO:0043535) | 3.59351941 |
| 99 | cAMP biosynthetic process (GO:0006171) | 3.59017769 |
| 100 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.57941557 |
| 101 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.54658414 |
| 102 | positive regulation of B cell differentiation (GO:0045579) | 3.54571300 |
| 103 | regulation of erythrocyte differentiation (GO:0045646) | 3.48140872 |
| 104 | positive regulation of fibroblast migration (GO:0010763) | 3.47868946 |
| 105 | myelin assembly (GO:0032288) | 3.47859861 |
| 106 | regulation of RIG-I signaling pathway (GO:0039535) | 3.47645418 |
| 107 | positive regulation of muscle hypertrophy (GO:0014742) | 3.44906166 |
| 108 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 3.44906166 |
| 109 | heparin biosynthetic process (GO:0030210) | 3.44706886 |
| 110 | heparin metabolic process (GO:0030202) | 3.44706886 |
| 111 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 3.44681714 |
| 112 | negative regulation of cell-matrix adhesion (GO:0001953) | 3.44371799 |
| 113 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.43199626 |
| 114 | positive regulation of chondrocyte differentiation (GO:0032332) | 3.42711271 |
| 115 | positive regulation of endothelial cell migration (GO:0010595) | 3.41588947 |
| 116 | regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947) | 3.41452229 |
| 117 | negative regulation of viral genome replication (GO:0045071) | 3.39501723 |
| 118 | protein complex disassembly (GO:0043241) | 3.38555942 |
| 119 | artery smooth muscle contraction (GO:0014824) | 3.37507995 |
| 120 | translational initiation (GO:0006413) | 3.36927722 |
| 121 | regulation of endothelial cell migration (GO:0010594) | 3.36911879 |
| 122 | negative regulation of chondrocyte differentiation (GO:0032331) | 3.35684622 |
| 123 | programmed necrotic cell death (GO:0097300) | 3.35351988 |
| 124 | positive regulation of hormone biosynthetic process (GO:0046886) | 3.33677290 |
| 125 | negative regulation of fibrinolysis (GO:0051918) | 3.33284274 |
| 126 | positive regulation of vasculogenesis (GO:2001214) | 3.33017096 |
| 127 | positive regulation of coagulation (GO:0050820) | 3.32205247 |
| 128 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.30785116 |
| 129 | substrate-dependent cell migration (GO:0006929) | 3.30206226 |
| 130 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 3.29231724 |
| 131 | negative regulation of histone methylation (GO:0031061) | 3.29154475 |
| 132 | regulation of natural killer cell differentiation (GO:0032823) | 3.28964489 |
| 133 | execution phase of apoptosis (GO:0097194) | 3.27673735 |
| 134 | angiogenesis (GO:0001525) | 3.26547928 |
| 135 | tonic smooth muscle contraction (GO:0014820) | 3.26429007 |
| 136 | positive regulation of receptor recycling (GO:0001921) | 3.24503714 |
| 137 | regulation of focal adhesion assembly (GO:0051893) | 3.22919165 |
| 138 | regulation of cell-substrate junction assembly (GO:0090109) | 3.22919165 |
| 139 | necrotic cell death (GO:0070265) | 3.22785500 |
| 140 | regulation of establishment of cell polarity (GO:2000114) | 3.20752413 |
| 141 | anatomical structure maturation (GO:0071695) | 3.20709339 |
| 142 | renal filtration (GO:0097205) | 3.20103487 |
| 143 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 3.19507857 |
| 144 | patterning of blood vessels (GO:0001569) | 3.17688130 |
| 145 | axon extension involved in axon guidance (GO:0048846) | 3.17657498 |
| 146 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.17657498 |
| 147 | T cell homeostasis (GO:0043029) | 3.16872919 |
| 148 | response to protozoan (GO:0001562) | 3.16171618 |
| 149 | positive regulation of macrophage activation (GO:0043032) | 3.15941876 |
| 150 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.15268889 |
| 151 | regulation of gamma-delta T cell activation (GO:0046643) | 3.14078022 |
| 152 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.12182699 |
| 153 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.12054133 |
| 154 | regulation of plasminogen activation (GO:0010755) | 3.11929234 |
| 155 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.09077152 |
| 156 | histamine transport (GO:0051608) | 3.08824098 |
| 157 | macromolecular complex disassembly (GO:0032984) | 3.08314928 |
| 158 | detection of other organism (GO:0098543) | 3.07788029 |
| 159 | defense response to protozoan (GO:0042832) | 3.06360091 |
| 160 | nephron epithelium development (GO:0072009) | 3.05859801 |
| 161 | regulation of adherens junction organization (GO:1903391) | 3.05712863 |
| 162 | endochondral ossification (GO:0001958) | 3.04884290 |
| 163 | replacement ossification (GO:0036075) | 3.04884290 |
| 164 | phospholipid scrambling (GO:0017121) | 2.99618028 |
| 165 | negative regulation of epithelial cell migration (GO:0010633) | 2.99576215 |
| 166 | positive regulation of steroid hormone secretion (GO:2000833) | 2.99556646 |
| 167 | negative regulation of angiogenesis (GO:0016525) | 2.99046108 |
| 168 | toxin transport (GO:1901998) | 2.99038375 |
| 169 | regulation of chondrocyte differentiation (GO:0032330) | 2.98977070 |
| 170 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.98907301 |
| 171 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.97696049 |
| 172 | negative regulation of DNA biosynthetic process (GO:2000279) | 2.96994524 |
| 173 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.96136723 |
| 174 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.95597670 |
| 175 | endocrine process (GO:0050886) | 2.95597670 |
| 176 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.95597670 |
| 177 | vascular smooth muscle contraction (GO:0014829) | 2.95235452 |
| 178 | positive regulation of cell size (GO:0045793) | 2.95039893 |
| 179 | regulation of granulocyte differentiation (GO:0030852) | 2.93293780 |
| 180 | blood vessel maturation (GO:0001955) | 2.92901561 |
| 181 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.92488346 |
| 182 | hyaluronan catabolic process (GO:0030214) | 2.92320562 |
| 183 | mRNA catabolic process (GO:0006402) | 2.87737867 |
| 184 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.84098793 |
| 185 | lymphoid progenitor cell differentiation (GO:0002320) | 2.81580646 |
| 186 | regulation of viral entry into host cell (GO:0046596) | 2.78787109 |
| 187 | response to type I interferon (GO:0034340) | 2.76111355 |
| 188 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.75418392 |
| 189 | cellular response to type I interferon (GO:0071357) | 2.72568641 |
| 190 | type I interferon signaling pathway (GO:0060337) | 2.72568641 |
| 191 | regulation of histone H3-K4 methylation (GO:0051569) | 2.71353630 |
| 192 | B cell mediated immunity (GO:0019724) | 2.70283665 |
| 193 | regulation of regulatory T cell differentiation (GO:0045589) | 2.68333643 |
| 194 | endosome to melanosome transport (GO:0035646) | 2.68043178 |
| 195 | endosome to pigment granule transport (GO:0043485) | 2.68043178 |
| 196 | endothelium development (GO:0003158) | 11.7271678 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SCL_19346495_ChIP-Seq_HPC-7_Human | 6.77057177 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.23895504 |
| 3 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.88284719 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.85831309 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.76681834 |
| 6 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.61664029 |
| 7 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.52417549 |
| 8 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.39968745 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.34386427 |
| 10 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 3.05158155 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.02182195 |
| 12 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.89603054 |
| 13 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.89442836 |
| 14 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.84813241 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.80607477 |
| 16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.80303442 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.78043725 |
| 18 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.69135292 |
| 19 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.68738929 |
| 20 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.59101218 |
| 21 | MYC_22102868_ChIP-Seq_BL_Human | 2.56755131 |
| 22 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.55160178 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.52842967 |
| 24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.51985855 |
| 25 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.40245627 |
| 26 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.37159897 |
| 27 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.29490580 |
| 28 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.25818331 |
| 29 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.15502273 |
| 30 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14439655 |
| 31 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.13755446 |
| 32 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.08906150 |
| 33 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.07399999 |
| 34 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.05415585 |
| 35 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.05028044 |
| 36 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.00818008 |
| 37 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.98126154 |
| 38 | GATA1_22025678_ChIP-Seq_K562_Human | 1.94957691 |
| 39 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.91911183 |
| 40 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.91413644 |
| 41 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.91028284 |
| 42 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.88393469 |
| 43 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.85819867 |
| 44 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.84953089 |
| 45 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.83702561 |
| 46 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.81692548 |
| 47 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.80925999 |
| 48 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.77917091 |
| 49 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.77333720 |
| 50 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.73215766 |
| 51 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71998933 |
| 52 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.71747071 |
| 53 | P300_19829295_ChIP-Seq_ESCs_Human | 1.69874449 |
| 54 | MAF_26560356_Chip-Seq_TH1_Human | 1.69794088 |
| 55 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.69357118 |
| 56 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.68278112 |
| 57 | VDR_22108803_ChIP-Seq_LS180_Human | 1.65428318 |
| 58 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.65079671 |
| 59 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.63580152 |
| 60 | CJUN_26792858_Chip-Seq_BT549_Human | 1.61786604 |
| 61 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.61613624 |
| 62 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.61472996 |
| 63 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.61472996 |
| 64 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.60691276 |
| 65 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.60445031 |
| 66 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.60384647 |
| 67 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.59150674 |
| 68 | GATA1_19941826_ChIP-Seq_K562_Human | 1.58839509 |
| 69 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.58567166 |
| 70 | SPI1_23127762_ChIP-Seq_K562_Human | 1.58264646 |
| 71 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.57088221 |
| 72 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.55472366 |
| 73 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.52629726 |
| 74 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.51816348 |
| 75 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.51620077 |
| 76 | MYB_26560356_Chip-Seq_TH2_Human | 1.50492894 |
| 77 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.49742233 |
| 78 | MYB_26560356_Chip-Seq_TH1_Human | 1.48882256 |
| 79 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.47425168 |
| 80 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.46907464 |
| 81 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.46468116 |
| 82 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.44648225 |
| 83 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.44078820 |
| 84 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42005112 |
| 85 | FUS_26573619_Chip-Seq_HEK293_Human | 1.39389583 |
| 86 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.37358239 |
| 87 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.36640600 |
| 88 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.35358123 |
| 89 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.34431730 |
| 90 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.33551681 |
| 91 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.32454541 |
| 92 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.29511016 |
| 93 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.29151169 |
| 94 | UTX_26944678_Chip-Seq_JUKART_Human | 1.29150451 |
| 95 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.26593382 |
| 96 | * IGF1R_20145208_ChIP-Seq_DFB_Human | 1.25995064 |
| 97 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.25736951 |
| 98 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.25056117 |
| 99 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.24064569 |
| 100 | EWS_26573619_Chip-Seq_HEK293_Human | 1.23302303 |
| 101 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.22641141 |
| 102 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.22590417 |
| 103 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.22143695 |
| 104 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.21312271 |
| 105 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.20718819 |
| 106 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.18277143 |
| 107 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.16039586 |
| 108 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.15829286 |
| 109 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.15103255 |
| 110 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.13980165 |
| 111 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.13557251 |
| 112 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.13369295 |
| 113 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.12660308 |
| 114 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.12607073 |
| 115 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.12509359 |
| 116 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.11742384 |
| 117 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11220860 |
| 118 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.11178469 |
| 119 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.10176549 |
| 120 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.09917938 |
| 121 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.09907677 |
| 122 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.09011734 |
| 123 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.08314659 |
| 124 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.07428095 |
| 125 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.07291842 |
| 126 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.07193226 |
| 127 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.06739510 |
| 128 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.05901546 |
| 129 | GATA2_19941826_ChIP-Seq_K562_Human | 1.05894413 |
| 130 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.05678128 |
| 131 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.04941206 |
| 132 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.02789237 |
| 133 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.01843400 |
| 134 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.00785039 |
| 135 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.00525978 |
| 136 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.00210897 |
| 137 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.99868880 |
| 138 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.99047823 |
| 139 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.98363305 |
| 140 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.98108409 |
| 141 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95937534 |
| 142 | STAT3_23295773_ChIP-Seq_U87_Human | 0.95651063 |
| 143 | GATA3_26560356_Chip-Seq_TH2_Human | 0.95311308 |
| 144 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.94898516 |
| 145 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.94361282 |
| 146 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93794805 |
| 147 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.93413845 |
| 148 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.93125356 |
| 149 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.93009307 |
| 150 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.92789785 |
| 151 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.92626937 |
| 152 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.92238308 |
| 153 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.91850570 |
| 154 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.91813568 |
| 155 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.91775042 |
| 156 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.91738178 |
| 157 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.91003113 |
| 158 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.90944654 |
| 159 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.89361093 |
| 160 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.88725752 |
| 161 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.87283084 |
| 162 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.87024747 |
| 163 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.87011266 |
| 164 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.85538852 |
| 165 | MAF_26560356_Chip-Seq_TH2_Human | 0.85500593 |
| 166 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.84803355 |
| 167 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.84788521 |
| 168 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.84301246 |
| 169 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84016054 |
| 170 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.83896307 |
| 171 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.83818307 |
| 172 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.83754531 |
| 173 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.83754531 |
| 174 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.83749901 |
| 175 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.82715813 |
| 176 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.78819419 |
| 177 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.78480568 |
| 178 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.77261489 |
| 179 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76246713 |
| 180 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.72908082 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005075_abnormal_melanosome_morpholog | 4.23580226 |
| 2 | MP0004272_abnormal_basement_membrane | 3.85741506 |
| 3 | MP0004808_abnormal_hematopoietic_stem | 3.85466776 |
| 4 | MP0003724_increased_susceptibility_to | 3.61165079 |
| 5 | MP0003303_peritoneal_inflammation | 3.59649467 |
| 6 | MP0010368_abnormal_lymphatic_system | 3.42981638 |
| 7 | MP0000465_gastrointestinal_hemorrhage | 3.33329717 |
| 8 | MP0002138_abnormal_hepatobiliary_system | 3.22730896 |
| 9 | MP0006054_spinal_hemorrhage | 3.22402149 |
| 10 | MP0002396_abnormal_hematopoietic_system | 3.21003037 |
| 11 | MP0003300_gastrointestinal_ulcer | 2.98030762 |
| 12 | MP0005464_abnormal_platelet_physiology | 2.92499907 |
| 13 | MP0009278_abnormal_bone_marrow | 2.82785277 |
| 14 | MP0009785_altered_susceptibility_to | 2.70696558 |
| 15 | MP0005084_abnormal_gallbladder_morpholo | 2.66947536 |
| 16 | MP0005397_hematopoietic_system_phenotyp | 2.60320904 |
| 17 | MP0001545_abnormal_hematopoietic_system | 2.60320904 |
| 18 | MP0001879_abnormal_lymphatic_vessel | 2.46111621 |
| 19 | MP0001835_abnormal_antigen_presentation | 2.39991521 |
| 20 | MP0000685_abnormal_immune_system | 2.33835419 |
| 21 | MP0005167_abnormal_blood-brain_barrier | 2.30188008 |
| 22 | MP0004147_increased_porphyrin_level | 2.29342809 |
| 23 | MP0005671_abnormal_response_to | 2.23811490 |
| 24 | MP0009379_abnormal_foot_pigmentation | 2.12586781 |
| 25 | MP0005174_abnormal_tail_pigmentation | 2.05720557 |
| 26 | MP0004084_abnormal_cardiac_muscle | 2.04906219 |
| 27 | MP0005595_abnormal_vascular_smooth | 1.96689148 |
| 28 | MP0003828_pulmonary_edema | 1.96641729 |
| 29 | MP0009697_abnormal_copulation | 1.93726736 |
| 30 | MP0003943_abnormal_hepatobiliary_system | 1.92510312 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.89544536 |
| 32 | MP0003436_decreased_susceptibility_to | 1.85360358 |
| 33 | MP0005025_abnormal_response_to | 1.80321259 |
| 34 | MP0004484_altered_response_of | 1.79243089 |
| 35 | MP0002398_abnormal_bone_marrow | 1.78605350 |
| 36 | MP0000490_abnormal_crypts_of | 1.73004923 |
| 37 | MP0009780_abnormal_chondrocyte_physiolo | 1.72336700 |
| 38 | MP0002722_abnormal_immune_system | 1.66947635 |
| 39 | MP0003866_abnormal_defecation | 1.62428946 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.61547459 |
| 41 | MP0002148_abnormal_hypersensitivity_rea | 1.59727005 |
| 42 | MP0001800_abnormal_humoral_immune | 1.59074526 |
| 43 | MP0003950_abnormal_plasma_membrane | 1.58485870 |
| 44 | MP0010030_abnormal_orbit_morphology | 1.56831226 |
| 45 | MP0003566_abnormal_cell_adhesion | 1.56430400 |
| 46 | MP0003763_abnormal_thymus_physiology | 1.52203351 |
| 47 | MP0002933_joint_inflammation | 1.52179467 |
| 48 | MP0002420_abnormal_adaptive_immunity | 1.48026961 |
| 49 | MP0002452_abnormal_antigen_presenting | 1.47762436 |
| 50 | MP0002127_abnormal_cardiovascular_syste | 1.45218175 |
| 51 | MP0001819_abnormal_immune_cell | 1.44367139 |
| 52 | MP0002723_abnormal_immune_serum | 1.43908310 |
| 53 | MP0003191_abnormal_cellular_cholesterol | 1.42699612 |
| 54 | MP0002166_altered_tumor_susceptibility | 1.40755483 |
| 55 | MP0005000_abnormal_immune_tolerance | 1.39606709 |
| 56 | MP0001853_heart_inflammation | 1.36537302 |
| 57 | MP0002419_abnormal_innate_immunity | 1.35116028 |
| 58 | MP0000716_abnormal_immune_system | 1.34872532 |
| 59 | MP0005387_immune_system_phenotype | 1.34245424 |
| 60 | MP0001790_abnormal_immune_system | 1.34245424 |
| 61 | MP0001614_abnormal_blood_vessel | 1.33015421 |
| 62 | MP0002429_abnormal_blood_cell | 1.31527604 |
| 63 | MP0009333_abnormal_splenocyte_physiolog | 1.31149052 |
| 64 | MP0005623_abnormal_meninges_morphology | 1.28321231 |
| 65 | MP0002132_abnormal_respiratory_system | 1.25264470 |
| 66 | MP0004782_abnormal_surfactant_physiolog | 1.24482411 |
| 67 | MP0004233_abnormal_muscle_weight | 1.23552842 |
| 68 | MP0002095_abnormal_skin_pigmentation | 1.22210842 |
| 69 | MP0004145_abnormal_muscle_electrophysio | 1.18910934 |
| 70 | MP0000703_abnormal_thymus_morphology | 1.17613774 |
| 71 | MP0004510_myositis | 1.15608895 |
| 72 | MP0002925_abnormal_cardiovascular_devel | 1.12528992 |
| 73 | MP0002168_other_aberrant_phenotype | 1.07248161 |
| 74 | MP0005165_increased_susceptibility_to | 1.07092260 |
| 75 | MP0003656_abnormal_erythrocyte_physiolo | 1.06403252 |
| 76 | MP0000613_abnormal_salivary_gland | 1.05675297 |
| 77 | MP0000343_altered_response_to | 1.03519999 |
| 78 | MP0003075_altered_response_to | 1.02811879 |
| 79 | MP0003385_abnormal_body_wall | 1.02513361 |
| 80 | MP0008961_abnormal_basal_metabolism | 1.02143596 |
| 81 | MP0001845_abnormal_inflammatory_respons | 1.01816096 |
| 82 | MP0004036_abnormal_muscle_relaxation | 1.00199886 |
| 83 | MP0000681_abnormal_thyroid_gland | 1.00107637 |
| 84 | MP0000371_diluted_coat_color | 1.00081961 |
| 85 | MP0003567_abnormal_fetal_cardiomyocyte | 0.99668330 |
| 86 | MP0006276_abnormal_autonomic_nervous | 0.99586399 |
| 87 | MP0001986_abnormal_taste_sensitivity | 0.99109685 |
| 88 | MP0008004_abnormal_stomach_pH | 0.98498252 |
| 89 | MP0003091_abnormal_cell_migration | 0.97539252 |
| 90 | MP0004215_abnormal_myocardial_fiber | 0.96290554 |
| 91 | MP0005360_urolithiasis | 0.96124647 |
| 92 | MP0009764_decreased_sensitivity_to | 0.95464128 |
| 93 | MP0000477_abnormal_intestine_morphology | 0.95286836 |
| 94 | MP0003868_abnormal_feces_composition | 0.93392759 |
| 95 | MP0001533_abnormal_skeleton_physiology | 0.93293081 |
| 96 | MP0000049_abnormal_middle_ear | 0.92591328 |
| 97 | MP0008469_abnormal_protein_level | 0.92272926 |
| 98 | MP0002128_abnormal_blood_circulation | 0.92199898 |
| 99 | MP0001873_stomach_inflammation | 0.92175107 |
| 100 | MP0002295_abnormal_pulmonary_circulatio | 0.90737862 |
| 101 | MP0003045_fibrosis | 0.90613136 |
| 102 | MP0008775_abnormal_heart_ventricle | 0.89581973 |
| 103 | MP0001293_anophthalmia | 0.87905172 |
| 104 | MP0005166_decreased_susceptibility_to | 0.87514396 |
| 105 | MP0002332_abnormal_exercise_endurance | 0.87317136 |
| 106 | MP0010352_gastrointestinal_tract_polyps | 0.86529174 |
| 107 | MP0001784_abnormal_fluid_regulation | 0.86521487 |
| 108 | MP0002877_abnormal_melanocyte_morpholog | 0.86011161 |
| 109 | MP0002075_abnormal_coat/hair_pigmentati | 0.85258636 |
| 110 | MP0004947_skin_inflammation | 0.83872181 |
| 111 | MP0001851_eye_inflammation | 0.83862788 |
| 112 | MP0003011_delayed_dark_adaptation | 0.83516776 |
| 113 | MP0003279_aneurysm | 0.83015912 |
| 114 | MP0001849_ear_inflammation | 0.81000013 |
| 115 | MP0005395_other_phenotype | 0.80677595 |
| 116 | MP0002160_abnormal_reproductive_system | 0.79226680 |
| 117 | MP0002006_tumorigenesis | 0.79065047 |
| 118 | MP0000013_abnormal_adipose_tissue | 0.79043232 |
| 119 | MP0004085_abnormal_heartbeat | 0.78709906 |
| 120 | MP0000747_muscle_weakness | 0.77197210 |
| 121 | MP0009763_increased_sensitivity_to | 0.77050168 |
| 122 | MP0001188_hyperpigmentation | 0.76650979 |
| 123 | MP0000230_abnormal_systemic_arterial | 0.76382494 |
| 124 | MP0001544_abnormal_cardiovascular_syste | 0.76307843 |
| 125 | MP0005385_cardiovascular_system_phenoty | 0.76307843 |
| 126 | MP0002405_respiratory_system_inflammati | 0.75900602 |
| 127 | MP0001664_abnormal_digestion | 0.75694422 |
| 128 | MP0000767_abnormal_smooth_muscle | 0.73276347 |
| 129 | MP0005409_darkened_coat_color | 0.71734328 |
| 130 | MP0000598_abnormal_liver_morphology | 0.71221821 |
| 131 | MP0010630_abnormal_cardiac_muscle | 0.70835967 |
| 132 | MP0003638_abnormal_response/metabolism_ | 0.70252645 |
| 133 | MP0000470_abnormal_stomach_morphology | 0.68739847 |
| 134 | MP0002928_abnormal_bile_duct | 0.68587115 |
| 135 | MP0000858_altered_metastatic_potential | 0.68247072 |
| 136 | MP0002932_abnormal_joint_morphology | 0.67593830 |
| 137 | MP0001958_emphysema | 0.67064264 |
| 138 | MP0009765_abnormal_xenobiotic_induced | 0.66802283 |
| 139 | MP0001663_abnormal_digestive_system | 0.66294844 |
| 140 | MP0000266_abnormal_heart_morphology | 0.65777547 |
| 141 | MP0000249_abnormal_blood_vessel | 0.65448824 |
| 142 | MP0002089_abnormal_postnatal_growth/wei | 0.64871783 |
| 143 | MP0002009_preneoplasia | 0.64810681 |
| 144 | MP0001348_abnormal_lacrimal_gland | 0.64809627 |
| 145 | MP0005220_abnormal_exocrine_pancreas | 0.63786173 |
| 146 | MP0001915_intracranial_hemorrhage | 0.63359338 |
| 147 | MP0003941_abnormal_skin_development | 0.61209182 |
| 148 | MP0009931_abnormal_skin_appearance | 0.60953036 |
| 149 | MP0004133_heterotaxia | 0.60095272 |
| 150 | MP0006138_congestive_heart_failure | 0.60062055 |
| 151 | MP0003935_abnormal_craniofacial_develop | 0.57657264 |
| 152 | MP0005023_abnormal_wound_healing | 0.56656703 |
| 153 | MP0002092_abnormal_eye_morphology | 0.55467518 |
| 154 | MP0003984_embryonic_growth_retardation | 0.52632935 |
| 155 | MP0002972_abnormal_cardiac_muscle | 0.50908863 |
| 156 | MP0002088_abnormal_embryonic_growth/wei | 0.50435502 |
| 157 | MP0000467_abnormal_esophagus_morphology | 0.50375709 |
| 158 | MP0004883_abnormal_blood_vessel | 0.48853804 |
| 159 | MP0002086_abnormal_extraembryonic_tissu | 0.48357468 |
| 160 | MP0002177_abnormal_outer_ear | 0.47358571 |
| 161 | MP0005197_abnormal_uvea_morphology | 0.46216013 |
| 162 | MP0005388_respiratory_system_phenotype | 0.45546218 |
| 163 | MP0002133_abnormal_respiratory_system | 0.45546218 |
| 164 | MP0003705_abnormal_hypodermis_morpholog | 0.44553463 |
| 165 | MP0001191_abnormal_skin_condition | 0.43975281 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Conjunctival telangiectasia (HP:0000524) | 6.17484007 |
| 2 | Visual hallucinations (HP:0002367) | 5.80335183 |
| 3 | Distal arthrogryposis (HP:0005684) | 5.74167531 |
| 4 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 5.51667769 |
| 5 | Prolonged bleeding time (HP:0003010) | 5.35001767 |
| 6 | Thrombocytosis (HP:0001894) | 5.30191024 |
| 7 | Peripheral hypomyelination (HP:0007182) | 5.29299509 |
| 8 | Ankle contracture (HP:0006466) | 5.16211355 |
| 9 | Stenosis of the external auditory canal (HP:0000402) | 5.12157949 |
| 10 | Esophageal varix (HP:0002040) | 4.96438370 |
| 11 | Amyotrophic lateral sclerosis (HP:0007354) | 4.93278826 |
| 12 | Cerebral hemorrhage (HP:0001342) | 4.76976440 |
| 13 | Axonal loss (HP:0003447) | 4.76351479 |
| 14 | Abnormality of the intrinsic pathway (HP:0010989) | 4.57723930 |
| 15 | Abnormality of the distal phalanges of the toes (HP:0010182) | 4.45302648 |
| 16 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.40462383 |
| 17 | Wrist flexion contracture (HP:0001239) | 4.38705223 |
| 18 | Joint hemorrhage (HP:0005261) | 4.34460097 |
| 19 | Syringomyelia (HP:0003396) | 4.24299904 |
| 20 | Spinal cord lesions (HP:0100561) | 4.24299904 |
| 21 | Decreased skull ossification (HP:0004331) | 4.23738506 |
| 22 | Skull defect (HP:0001362) | 4.08486372 |
| 23 | Epistaxis (HP:0000421) | 3.97200687 |
| 24 | Aplastic anemia (HP:0001915) | 3.90506546 |
| 25 | Broad alveolar ridges (HP:0000187) | 3.88645424 |
| 26 | Abnormality of skull ossification (HP:0002703) | 3.80496900 |
| 27 | Adactyly (HP:0009776) | 3.72619461 |
| 28 | Spondylolisthesis (HP:0003302) | 3.66871011 |
| 29 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 3.66756930 |
| 30 | Spontaneous hematomas (HP:0007420) | 3.58855190 |
| 31 | Arterial tortuosity (HP:0005116) | 3.56541120 |
| 32 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.54297301 |
| 33 | IgM deficiency (HP:0002850) | 3.51488105 |
| 34 | Mucosal telangiectasiae (HP:0100579) | 3.50361730 |
| 35 | Fatigue (HP:0012378) | 3.49448196 |
| 36 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 3.48648281 |
| 37 | Abnormal number of erythroid precursors (HP:0012131) | 3.41276962 |
| 38 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 3.39055481 |
| 39 | Short 4th metacarpal (HP:0010044) | 3.39055481 |
| 40 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 3.37242794 |
| 41 | Gingival bleeding (HP:0000225) | 3.33109212 |
| 42 | Protrusio acetabuli (HP:0003179) | 3.32524803 |
| 43 | Petechiae (HP:0000967) | 3.26759627 |
| 44 | Glossoptosis (HP:0000162) | 3.25593518 |
| 45 | Purpura (HP:0000979) | 3.15526244 |
| 46 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 3.12723308 |
| 47 | Premature loss of primary teeth (HP:0006323) | 3.10873728 |
| 48 | Pigmentary retinal degeneration (HP:0001146) | 3.10195685 |
| 49 | Abnormal platelet function (HP:0011869) | 3.05878309 |
| 50 | Impaired platelet aggregation (HP:0003540) | 3.05878309 |
| 51 | Frequent falls (HP:0002359) | 3.05834176 |
| 52 | Abnormality of the frontal sinuses (HP:0002687) | 3.03967120 |
| 53 | Vascular tortuosity (HP:0004948) | 3.03951761 |
| 54 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 3.03792066 |
| 55 | Absent frontal sinuses (HP:0002688) | 2.96449906 |
| 56 | Abnormality of the 4th metacarpal (HP:0010012) | 2.95008589 |
| 57 | Visceral angiomatosis (HP:0100761) | 2.94689997 |
| 58 | Abnormality of the nasal mucosa (HP:0000433) | 2.94625808 |
| 59 | Amaurosis fugax (HP:0100576) | 2.92451076 |
| 60 | Myotonia (HP:0002486) | 2.92424701 |
| 61 | Myositis (HP:0100614) | 2.91048255 |
| 62 | Absent thumb (HP:0009777) | 2.88856566 |
| 63 | Myelodysplasia (HP:0002863) | 2.86807397 |
| 64 | Arterial thrombosis (HP:0004420) | 2.84482213 |
| 65 | Hemangiomatosis (HP:0007461) | 2.84213786 |
| 66 | Overgrowth (HP:0001548) | 2.83090189 |
| 67 | Microcytic anemia (HP:0001935) | 2.79512833 |
| 68 | Aortic aneurysm (HP:0004942) | 2.75532102 |
| 69 | Sparse scalp hair (HP:0002209) | 2.75323908 |
| 70 | Spontaneous abortion (HP:0005268) | 2.71114672 |
| 71 | Reticulocytopenia (HP:0001896) | 2.64998992 |
| 72 | Vertebral clefting (HP:0008428) | 2.63850784 |
| 73 | Tetraparesis (HP:0002273) | 2.58428887 |
| 74 | Spinal rigidity (HP:0003306) | 2.57450228 |
| 75 | Abnormality of the alveolar ridges (HP:0006477) | 2.54978179 |
| 76 | Asplenia (HP:0001746) | 2.54020784 |
| 77 | Abnormal vertebral ossification (HP:0100569) | 2.53889884 |
| 78 | Sparse eyelashes (HP:0000653) | 2.53359049 |
| 79 | Subcapsular cataract (HP:0000523) | 2.48269636 |
| 80 | Nonprogressive disorder (HP:0003680) | 2.47511671 |
| 81 | Pallor (HP:0000980) | 2.47373581 |
| 82 | Aortic valve stenosis (HP:0001650) | 2.43968774 |
| 83 | Cellulitis (HP:0100658) | 2.43900620 |
| 84 | Abnormal platelet volume (HP:0011876) | 2.42401428 |
| 85 | Severe global developmental delay (HP:0011344) | 2.41465506 |
| 86 | Cavernous hemangioma (HP:0001048) | 2.39520736 |
| 87 | Chest pain (HP:0100749) | 2.37951914 |
| 88 | Orchitis (HP:0100796) | 2.35529144 |
| 89 | Beaking of vertebral bodies (HP:0004568) | 2.35119048 |
| 90 | Neonatal death (HP:0003811) | 2.34996497 |
| 91 | Acute myeloid leukemia (HP:0004808) | 2.34823679 |
| 92 | Menorrhagia (HP:0000132) | 2.34366419 |
| 93 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.33761606 |
| 94 | Pulmonary hypertension (HP:0002092) | 2.33230520 |
| 95 | Cervical subluxation (HP:0003308) | 2.31704581 |
| 96 | Bruising susceptibility (HP:0000978) | 2.29172655 |
| 97 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.24114594 |
| 98 | Vacuolated lymphocytes (HP:0001922) | 2.22611806 |
| 99 | Lymphangioma (HP:0100764) | 2.20479013 |
| 100 | High pitched voice (HP:0001620) | 2.20064469 |
| 101 | Gonadotropin excess (HP:0000837) | 2.19228559 |
| 102 | Type 2 muscle fiber atrophy (HP:0003554) | 2.18988319 |
| 103 | Short clavicles (HP:0000894) | 2.17989812 |
| 104 | Mitral valve prolapse (HP:0001634) | 2.17693010 |
| 105 | Stroke (HP:0001297) | 2.16934815 |
| 106 | Hip contracture (HP:0003273) | 2.16717748 |
| 107 | Joint contractures involving the joints of the feet (HP:0100492) | 2.15441877 |
| 108 | Flexion contracture of toe (HP:0005830) | 2.15441877 |
| 109 | Bifid uvula (HP:0000193) | 2.15240038 |
| 110 | Porencephaly (HP:0002132) | 2.14907167 |
| 111 | Weak cry (HP:0001612) | 2.11235974 |
| 112 | Fused cervical vertebrae (HP:0002949) | 2.09593549 |
| 113 | Tinnitus (HP:0000360) | 2.08077769 |
| 114 | Abnormality of T cell physiology (HP:0011840) | 2.06195653 |
| 115 | Muscle fiber atrophy (HP:0100295) | 2.05395580 |
| 116 | Aortic dissection (HP:0002647) | 2.03743066 |
| 117 | Capillary hemangiomas (HP:0005306) | 2.00126643 |
| 118 | Pulmonary embolism (HP:0002204) | 2.00001766 |
| 119 | Recurrent bronchitis (HP:0002837) | 1.99449397 |
| 120 | Occipital encephalocele (HP:0002085) | 1.99236883 |
| 121 | Increased mean platelet volume (HP:0011877) | 1.97333942 |
| 122 | Thrombophlebitis (HP:0004418) | 1.96126831 |
| 123 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.95676401 |
| 124 | Congenital, generalized hypertrichosis (HP:0004540) | 1.91976492 |
| 125 | Coxa valga (HP:0002673) | 1.91716459 |
| 126 | Tapered finger (HP:0001182) | 1.89994204 |
| 127 | Posterior subcapsular cataract (HP:0007787) | 1.88666944 |
| 128 | Optic neuritis (HP:0100653) | 1.87217217 |
| 129 | Retrobulbar optic neuritis (HP:0100654) | 1.87217217 |
| 130 | Portal hypertension (HP:0001409) | 1.87164210 |
| 131 | Volvulus (HP:0002580) | 1.86332044 |
| 132 | Disproportionate short-trunk short stature (HP:0003521) | 1.86034473 |
| 133 | Migraine (HP:0002076) | 1.85882995 |
| 134 | Aplasia/Hypoplasia of the clavicles (HP:0006710) | 1.85458832 |
| 135 | Hematochezia (HP:0002573) | 1.85252937 |
| 136 | Vertigo (HP:0002321) | 1.83379833 |
| 137 | Erythema (HP:0010783) | 1.83055469 |
| 138 | Cerebral aneurysm (HP:0004944) | 1.82583383 |
| 139 | Absent hand (HP:0004050) | 1.82167466 |
| 140 | Vertebral compression fractures (HP:0002953) | 1.80465356 |
| 141 | Interstitial pulmonary disease (HP:0006530) | 1.80147367 |
| 142 | Hemorrhage of the eye (HP:0011885) | 1.80075921 |
| 143 | Striae distensae (HP:0001065) | 1.80073386 |
| 144 | Annular pancreas (HP:0001734) | 1.79173925 |
| 145 | Neoplasm of the oral cavity (HP:0100649) | 1.79111591 |
| 146 | Hypochromic anemia (HP:0001931) | 1.78155357 |
| 147 | Periodontitis (HP:0000704) | 1.78057613 |
| 148 | Flat face (HP:0012368) | 1.75472729 |
| 149 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.74809875 |
| 150 | Abnormality of the hepatic vasculature (HP:0006707) | 1.74609985 |
| 151 | Flat acetabular roof (HP:0003180) | 1.74292674 |
| 152 | Broad face (HP:0000283) | 1.74221000 |
| 153 | Nasal polyposis (HP:0100582) | 1.72332863 |
| 154 | Polycythemia (HP:0001901) | 1.72124147 |
| 155 | Reduced antithrombin III activity (HP:0001976) | 1.71961335 |
| 156 | Gastrointestinal stroma tumor (HP:0100723) | 1.71438765 |
| 157 | Hyperlipoproteinemia (HP:0010980) | 1.70163182 |
| 158 | Orthostatic hypotension (HP:0001278) | 1.68940908 |
| 159 | Difficulty climbing stairs (HP:0003551) | 1.68221407 |
| 160 | Venous insufficiency (HP:0005293) | 1.68000992 |
| 161 | Bulbous nose (HP:0000414) | 1.65799535 |
| 162 | Thoracolumbar scoliosis (HP:0002944) | 1.62716588 |
| 163 | Congenital hepatic fibrosis (HP:0002612) | 1.62065674 |
| 164 | Abnormality of the right ventricle (HP:0001707) | 1.60134530 |
| 165 | Teleangiectasia of the skin (HP:0100585) | 1.57547612 |
| 166 | Nonimmune hydrops fetalis (HP:0001790) | 1.56470212 |
| 167 | Vertebral hypoplasia (HP:0008417) | 1.55095498 |
| 168 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.55095498 |
| 169 | Congenital hip dislocation (HP:0001374) | 1.54005905 |
| 170 | Limited hip movement (HP:0008800) | 1.52491225 |
| 171 | Scotoma (HP:0000575) | 1.51832863 |
| 172 | Full cheeks (HP:0000293) | 1.51020683 |
| 173 | Abnormality of the acetabulum (HP:0003170) | 1.50527258 |
| 174 | Intestinal polyposis (HP:0200008) | 1.50369238 |
| 175 | Cerebral ischemia (HP:0002637) | 1.50030255 |
| 176 | Incomplete penetrance (HP:0003829) | 1.49997665 |
| 177 | Fibular aplasia (HP:0002990) | 1.49690021 |
| 178 | Hemoptysis (HP:0002105) | 1.48428069 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PIK3CG | 6.76266057 |
| 2 | TIE1 | 5.56817652 |
| 3 | TGFBR1 | 3.50789013 |
| 4 | TGFBR2 | 2.95477006 |
| 5 | MUSK | 2.94956073 |
| 6 | KDR | 2.80644986 |
| 7 | IKBKE | 2.57678953 |
| 8 | FER | 2.53052802 |
| 9 | JAK3 | 2.17337438 |
| 10 | RPS6KA4 | 2.10532140 |
| 11 | MAP4K1 | 2.10446124 |
| 12 | KIT | 2.06141453 |
| 13 | MAP2K3 | 1.99054869 |
| 14 | ADRBK2 | 1.90954506 |
| 15 | EEF2K | 1.85434622 |
| 16 | ERN1 | 1.84742876 |
| 17 | BTK | 1.83790693 |
| 18 | ITK | 1.83372412 |
| 19 | MATK | 1.76353687 |
| 20 | EPHB2 | 1.71609268 |
| 21 | PTK2B | 1.69210115 |
| 22 | MKNK1 | 1.61466007 |
| 23 | RPS6KB2 | 1.58117651 |
| 24 | IKBKB | 1.53552074 |
| 25 | TEC | 1.52999934 |
| 26 | CDK19 | 1.52689538 |
| 27 | DYRK3 | 1.49023507 |
| 28 | FLT3 | 1.45181765 |
| 29 | PTK2 | 1.42737010 |
| 30 | ZAP70 | 1.42110236 |
| 31 | MAP2K6 | 1.35351768 |
| 32 | MAP3K12 | 1.32451171 |
| 33 | MYLK | 1.29949596 |
| 34 | PRKG2 | 1.29044272 |
| 35 | PKN2 | 1.24070680 |
| 36 | PASK | 1.21735371 |
| 37 | TBK1 | 1.19712846 |
| 38 | TXK | 1.18775436 |
| 39 | NME2 | 1.16910128 |
| 40 | SYK | 1.15636427 |
| 41 | CDK8 | 1.08059555 |
| 42 | MAPKAPK5 | 1.03392711 |
| 43 | CSK | 0.99446976 |
| 44 | CAMKK2 | 0.97136934 |
| 45 | VRK1 | 0.95082492 |
| 46 | NTRK1 | 0.91190096 |
| 47 | TRPM7 | 0.90103243 |
| 48 | CDC7 | 0.89647309 |
| 49 | BLK | 0.88557445 |
| 50 | GRK1 | 0.83770439 |
| 51 | FGFR3 | 0.81411695 |
| 52 | PIK3CA | 0.80393439 |
| 53 | LYN | 0.80288007 |
| 54 | TNK2 | 0.79832856 |
| 55 | EIF2AK3 | 0.79712871 |
| 56 | HIPK2 | 0.77806373 |
| 57 | MAPKAPK3 | 0.75943539 |
| 58 | MAP3K13 | 0.73572965 |
| 59 | CCNB1 | 0.72997388 |
| 60 | STK24 | 0.70597467 |
| 61 | DAPK1 | 0.69564394 |
| 62 | CHUK | 0.69440715 |
| 63 | BCKDK | 0.68769071 |
| 64 | NUAK1 | 0.67762280 |
| 65 | RPS6KA6 | 0.67012632 |
| 66 | TTN | 0.66001685 |
| 67 | LRRK2 | 0.65912858 |
| 68 | MAPK4 | 0.63455101 |
| 69 | MKNK2 | 0.62834467 |
| 70 | PIM1 | 0.62817040 |
| 71 | RPS6KA5 | 0.61102498 |
| 72 | FES | 0.60483265 |
| 73 | LCK | 0.59089349 |
| 74 | STK16 | 0.57151657 |
| 75 | FRK | 0.57065091 |
| 76 | BMPR1B | 0.56698203 |
| 77 | CSF1R | 0.56220248 |
| 78 | WEE1 | 0.55645917 |
| 79 | PLK2 | 0.55351022 |
| 80 | CDK6 | 0.54889945 |
| 81 | GRK5 | 0.50616687 |
| 82 | CAMK1 | 0.48835502 |
| 83 | CAMK4 | 0.48793286 |
| 84 | EPHA3 | 0.47757733 |
| 85 | HCK | 0.47519197 |
| 86 | TAOK3 | 0.46096368 |
| 87 | MAPK11 | 0.45456018 |
| 88 | PAK4 | 0.44444175 |
| 89 | IRAK4 | 0.43848166 |
| 90 | CLK1 | 0.43649866 |
| 91 | IGF1R | 0.42092059 |
| 92 | TNIK | 0.41958821 |
| 93 | NLK | 0.40999046 |
| 94 | EGFR | 0.39234179 |
| 95 | RPS6KC1 | 0.38792939 |
| 96 | RPS6KL1 | 0.38792939 |
| 97 | MET | 0.37832490 |
| 98 | PRKCE | 0.37510987 |
| 99 | INSR | 0.37361275 |
| 100 | ACVR1B | 0.36925660 |
| 101 | PDGFRB | 0.36696905 |
| 102 | SGK2 | 0.35781410 |
| 103 | MAPK12 | 0.35522095 |
| 104 | SRC | 0.34688021 |
| 105 | ERBB3 | 0.34240167 |
| 106 | MAPK3 | 0.33692678 |
| 107 | ATR | 0.32043681 |
| 108 | FGFR2 | 0.31419073 |
| 109 | RPS6KA2 | 0.31375369 |
| 110 | DAPK3 | 0.31340862 |
| 111 | PRKAA2 | 0.30162971 |
| 112 | PAK6 | 0.30039178 |
| 113 | IRAK3 | 0.29936855 |
| 114 | ZAK | 0.29280837 |
| 115 | CDK9 | 0.28157572 |
| 116 | BMX | 0.27956187 |
| 117 | EPHB1 | 0.27932491 |
| 118 | JAK2 | 0.27840540 |
| 119 | IRAK1 | 0.27699231 |
| 120 | JAK1 | 0.27214761 |
| 121 | YES1 | 0.26603226 |
| 122 | PTK6 | 0.26240770 |
| 123 | TYK2 | 0.25917770 |
| 124 | CSNK1G3 | 0.25861566 |
| 125 | CSNK1G1 | 0.24500942 |
| 126 | ROCK1 | 0.23805661 |
| 127 | ROCK2 | 0.22727407 |
| 128 | AURKB | 0.21984394 |
| 129 | ABL1 | 0.21079137 |
| 130 | MAP4K2 | 0.20775572 |
| 131 | PRKD1 | 0.20050232 |
| 132 | CDK7 | 0.19670017 |
| 133 | FYN | 0.19495946 |
| 134 | STK3 | 0.19415555 |
| 135 | MOS | 0.18990370 |
| 136 | CAMK1D | 0.18928078 |
| 137 | BRSK2 | 0.18679222 |
| 138 | NTRK2 | 0.18544968 |
| 139 | ILK | 0.18018901 |
| 140 | MAP3K6 | 0.17798972 |
| 141 | PRKG1 | 0.17639581 |
| 142 | PDGFRA | 0.17507758 |
| 143 | PDK1 | 0.17462655 |
| 144 | ADRBK1 | 0.16147590 |
| 145 | STK4 | 0.15874831 |
| 146 | DAPK2 | 0.15779722 |
| 147 | PAK2 | 0.15107030 |
| 148 | FGR | 0.13833640 |
| 149 | MAP2K4 | 0.13515973 |
| 150 | SGK3 | 0.12974534 |
| 151 | MAP3K11 | 0.11229404 |
| 152 | RET | 0.10851664 |
| 153 | STK10 | 0.10805758 |
| 154 | PINK1 | 0.10507352 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.74956189 |
| 2 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 3.46279646 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.42611824 |
| 4 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 3.35143662 |
| 5 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.63381600 |
| 6 | Platelet activation_Homo sapiens_hsa04611 | 2.58753138 |
| 7 | DNA replication_Homo sapiens_hsa03030 | 2.25718250 |
| 8 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.23094575 |
| 9 | Mismatch repair_Homo sapiens_hsa03430 | 2.17144660 |
| 10 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 2.08184170 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.04102520 |
| 12 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.97209434 |
| 13 | Measles_Homo sapiens_hsa05162 | 1.96804773 |
| 14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.92132183 |
| 15 | Base excision repair_Homo sapiens_hsa03410 | 1.80887089 |
| 16 | Leishmaniasis_Homo sapiens_hsa05140 | 1.73410086 |
| 17 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.73023373 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.65361900 |
| 19 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.61649978 |
| 20 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.60324770 |
| 21 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.57936407 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.53432468 |
| 23 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.52762348 |
| 24 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.52738135 |
| 25 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.52635881 |
| 26 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.51821017 |
| 27 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.48763992 |
| 28 | Adherens junction_Homo sapiens_hsa04520 | 1.47338692 |
| 29 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.45251313 |
| 30 | Gap junction_Homo sapiens_hsa04540 | 1.44347693 |
| 31 | Hepatitis B_Homo sapiens_hsa05161 | 1.43466662 |
| 32 | Malaria_Homo sapiens_hsa05144 | 1.43428192 |
| 33 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.39833435 |
| 34 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.37955694 |
| 35 | Legionellosis_Homo sapiens_hsa05134 | 1.36245468 |
| 36 | Influenza A_Homo sapiens_hsa05164 | 1.31868408 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.31808014 |
| 38 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.31452028 |
| 39 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.30766431 |
| 40 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.29805100 |
| 41 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.28045332 |
| 42 | Other glycan degradation_Homo sapiens_hsa00511 | 1.24004479 |
| 43 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.23247690 |
| 44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.21188333 |
| 45 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.20184921 |
| 46 | Renin secretion_Homo sapiens_hsa04924 | 1.20146561 |
| 47 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.18218739 |
| 48 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.17141041 |
| 49 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.16676210 |
| 50 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.16174376 |
| 51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.12808360 |
| 52 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.11905236 |
| 53 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.11450959 |
| 54 | Long-term depression_Homo sapiens_hsa04730 | 1.09121401 |
| 55 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.08849308 |
| 56 | Ras signaling pathway_Homo sapiens_hsa04014 | 1.08469321 |
| 57 | Pertussis_Homo sapiens_hsa05133 | 1.07903232 |
| 58 | Shigellosis_Homo sapiens_hsa05131 | 1.05980400 |
| 59 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.05512309 |
| 60 | Purine metabolism_Homo sapiens_hsa00230 | 1.04953544 |
| 61 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.04891172 |
| 62 | RNA degradation_Homo sapiens_hsa03018 | 1.04140252 |
| 63 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.03085411 |
| 64 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.02925996 |
| 65 | Olfactory transduction_Homo sapiens_hsa04740 | 1.02531493 |
| 66 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.01846593 |
| 67 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.01150808 |
| 68 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.99110729 |
| 69 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.96942597 |
| 70 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.96517039 |
| 71 | Axon guidance_Homo sapiens_hsa04360 | 0.96106138 |
| 72 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.96031904 |
| 73 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.96024595 |
| 74 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.95659221 |
| 75 | Homologous recombination_Homo sapiens_hsa03440 | 0.95304996 |
| 76 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.94747228 |
| 77 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.92393441 |
| 78 | Alcoholism_Homo sapiens_hsa05034 | 0.89114648 |
| 79 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.88939522 |
| 80 | RNA polymerase_Homo sapiens_hsa03020 | 0.87343732 |
| 81 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.86820859 |
| 82 | Spliceosome_Homo sapiens_hsa03040 | 0.85629772 |
| 83 | Salmonella infection_Homo sapiens_hsa05132 | 0.83643471 |
| 84 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.82523603 |
| 85 | Salivary secretion_Homo sapiens_hsa04970 | 0.82400183 |
| 86 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.81176238 |
| 87 | Circadian entrainment_Homo sapiens_hsa04713 | 0.81068408 |
| 88 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.80932796 |
| 89 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.80783586 |
| 90 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.79871165 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.79232567 |
| 92 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.75888920 |
| 93 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.74184023 |
| 94 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.73926531 |
| 95 | Melanogenesis_Homo sapiens_hsa04916 | 0.73898670 |
| 96 | Taste transduction_Homo sapiens_hsa04742 | 0.73259929 |
| 97 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.72350874 |
| 98 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.72289758 |
| 99 | Apoptosis_Homo sapiens_hsa04210 | 0.71999542 |
| 100 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.70765484 |
| 101 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69844775 |
| 102 | Hepatitis C_Homo sapiens_hsa05160 | 0.69223340 |
| 103 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.68875764 |
| 104 | Morphine addiction_Homo sapiens_hsa05032 | 0.67704327 |
| 105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.67157495 |
| 106 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.64163067 |
| 107 | Tight junction_Homo sapiens_hsa04530 | 0.63914899 |
| 108 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.62164719 |
| 109 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.61563064 |
| 110 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.60676977 |
| 111 | Cell cycle_Homo sapiens_hsa04110 | 0.60085178 |
| 112 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.60034130 |
| 113 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.59953272 |
| 114 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.58564338 |
| 115 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.58479344 |
| 116 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57874056 |
| 117 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.56977082 |
| 118 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.56921866 |
| 119 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.56580480 |
| 120 | Phagosome_Homo sapiens_hsa04145 | 0.56488028 |
| 121 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.55998369 |
| 122 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.55816171 |
| 123 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53648252 |
| 124 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.52925203 |
| 125 | Endocytosis_Homo sapiens_hsa04144 | 0.52170232 |
| 126 | Galactose metabolism_Homo sapiens_hsa00052 | 0.50498588 |
| 127 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49964505 |
| 128 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.49796869 |
| 129 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.48540216 |
| 130 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48147388 |
| 131 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.46540929 |
| 132 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.46069304 |
| 133 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.45123237 |
| 134 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.45043567 |
| 135 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.44785484 |
| 136 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.43605686 |
| 137 | Bladder cancer_Homo sapiens_hsa05219 | 0.43093749 |
| 138 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.42958620 |
| 139 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.41850262 |
| 140 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.40625408 |
| 141 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.40410823 |
| 142 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.40293375 |
| 143 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.40093276 |
| 144 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39970665 |
| 145 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.39787562 |
| 146 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.39150286 |
| 147 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.38874769 |
| 148 | Amoebiasis_Homo sapiens_hsa05146 | 0.38805086 |
| 149 | Focal adhesion_Homo sapiens_hsa04510 | 0.38769808 |
| 150 | Pathways in cancer_Homo sapiens_hsa05200 | 0.37887695 |
| 151 | Colorectal cancer_Homo sapiens_hsa05210 | 0.37124926 |
| 152 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.36996471 |
| 153 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.35756264 |
| 154 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35661566 |
| 155 | Insulin resistance_Homo sapiens_hsa04931 | 0.35641816 |
| 156 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.35394872 |
| 157 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.35138628 |
| 158 | RNA transport_Homo sapiens_hsa03013 | 0.35097522 |
| 159 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.31478492 |
| 160 | ABC transporters_Homo sapiens_hsa02010 | 0.30965377 |
| 161 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.30632557 |
| 162 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.29469725 |
| 163 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.29434042 |

